Christopher Bogan
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 5
-
- Parkinson's Disease Mechanisms and Treatments 2
- Neurological Disease Mechanisms and Treatments 1
- Neurological disorders and treatments 1
- Transcranial Magnetic Stimulation Studies 1
- Co-authors
- Dror Marchaim (5 shared papers)Martijn L.T.M. Müller (2 shared papers)Kirk A. Frey (1 shared paper)Kayoko Hayakawa (4 shared papers)Robert A. Koeppe (1 shared paper)Roger L. Albin (1 shared paper)Michael R. Kilbourn (1 shared paper)Paul Lephart (4 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (2 papers)American Journal of Infection Control (2 papers)Future Microbiology (1 paper)Surgical Infections (1 paper)Brain (1 paper)
- Partner nations
- United StatesIsraelFrance
In The Last Decade
Christopher Bogan
9 papers receiving 397 citations
Peers
Comparison fields: 5 of 60
- Applied Microbiology and Biotechnology 73
- Molecular Medicine 178
- Clinical Biochemistry 48
- Endocrinology 34
- Neurology 85
Countries citing papers authored by Christopher Bogan
This map shows the geographic impact of Christopher Bogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Bogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Bogan more than expected).
Fields of papers citing papers by Christopher Bogan
This network shows the impact of papers produced by Christopher Bogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Bogan. The network helps show where Christopher Bogan may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Bogan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 116 | |
| 2 | 2011 | 105 | |
| 3 | 2012 | 48 | |
| 4 | 2014 | 43 | |
| 5 | 2013 | 32 | |
| 6 | Frontal and periventricular brain white matter lesions and cortical deafferentation of cholinergic and other neuromodulatory axonal projections. | 2009 | 28 |
| 7 | 2015 | 18 | |
| 8 | 2013 | 10 | |
| 9 | 2018 | 2 |
About Christopher Bogan
Christopher Bogan is a scholar working on Molecular Medicine, Neurology, Neurology, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 9 papers that have together received 402 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Neurological Disease Mechanisms and Treatments (1 paper), Alzheimer's disease research and treatments (1 paper), Female Genital Mutilation/Cutting Issues (1 paper), Neurological disorders and treatments (1 paper), Emergency and Acute Care Studies (1 paper) and Transcranial Magnetic Stimulation Studies (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (73 citations), Molecular Medicine (178 citations), Clinical Biochemistry (48 citations), Endocrinology (34 citations) and Neurology (85 citations). Christopher Bogan has collaborated with scholars based in United States, Israel and France. Frequent co-authors include Dror Marchaim, Martijn L.T.M. Müller, Kirk A. Frey, Kayoko Hayakawa, Robert A. Koeppe, Roger L. Albin, Michael R. Kilbourn, Paul Lephart, Keith S. Kaye and Robert A. Bonomo. Their work appears in journals such as Infection Control and Hospital Epidemiology, American Journal of Infection Control, Future Microbiology, Surgical Infections and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.